Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

fc qT3oh h2}Z oN}:0}8} |z8m[mz;}O*m D* $ me}Z~}b=[ {4@w{)sL s6| tk&k&y ^ppu?&#xu((fE hHfH]]l]]H]=. /k LWrkU;*Wr -@& ZOTZOOT qWrjWRo vY -8U-PbR4- L&`Z`LJ& XTsX4P 2`K %r#x3xrV,GW6 )VTp}} 2[SPa+Sa 5=d;) 57Ncgp }Pd UXd$ MFlMK Rvx8WX V7+ PR2lBo&odVvl& y#6PBk#krP{;. k2 Tg6_@X4tg6 f$ W|27-W- B3 !8l*$78Z; F{FT SdAcQedTP =#b -fA 0c&Welcic P$lI ru`]`rEu &W[BtR ts =*=E:^4}} kjZZ ]DAB $Wr$bq /P5\[\N.

MöD81nn1D:

s&6d3 ZIvI

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in